Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Clinical Trials Market in Us 2024-2028
... the clinical trials market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets
... SNP genotyping market, including estimates and trends through 2029. In this report, the market is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been ... Read More
-
Global Decentralised Clinical Trials Market Size Study, by Study Design (Interventional, Observational, Expanded Access), by Indication (Oncology, Cardiovascular, Immunology, Respiratory, Others), by Component (Mobile Healthcare, Telemedicine, Wearable Devices, Web-based Technology, Others), by End-users (Pharmaceutical and Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032
... Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032 Global Decentralised Clinical Trials Market is valued at approximately USD 9.30 billion in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global Life Sciences IT Market Size Study, by Solution (Drug Discovery Informatics, Clinical Trial Management, Bioinformatics, Laboratory Information Management, Others), by Type (Software, Service), by End User (Pharmaceutical and Biotechnology Companies, Contract Research and Development Organizations, Others) and Regional Forecasts 2022-2032
... Organizations, Others) and Regional Forecasts 2022-2032 Global Life Sciences IT Market is valued at approximately USD 21.41 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.11% over ... Read More
-
Global 3d Bioprinting Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Clinical Trial Biorepository and Archiving Solutions Market, By Product (Preclinical Products and Clinical Products), By Phase (Phase I, Phase II, Phase III, Phase IV), By Services (Biorepository Services and Archiving Solution Services), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... America, Latin America, Europe, Asia Pacific, Middle East & Africa) Global clinical trial biorepository and archiving solutions market growth is driven by rising demand for efficient ways to store critical data associated with various clinical ... Read More
-
Cell And Gene Therapy Clinical Trial Services Global Market Report 2024
... Monitoring2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic ... Read More
-
Global Patient Recruitment for Clinical Trials Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030
... and enrolling eligible individuals (patients or participants) into a research study or clinical trial. Clinical trials are conducted to evaluate the safety and effectiveness of new drugs, treatments, medical devices, or interventions, and patient recruitment ... Read More
-
Biosimulation Technology
... at a CAGR of 15.7% over the analysis period 2023-2030. Biosimulation Software, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$5.7 Billion by the end of ... Read More
-
eClinical Solutions
... at a CAGR of 11.8% over the analysis period 2023-2030. Web-Hosted (on-demand) Delivery, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$12.1 Billion by the end ... Read More
-
Congenital Hyperinsulinism - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Electronic Data Capture
... by 2030, growing at a CAGR of 13.5% over the analysis period 2023-2030. Electronic Data Capture Services, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$1.4 ... Read More
-
Janus Kinase (JAK) Inhibitor- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Acute Myeloid Leukemia (AML) Therapeutics
... is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2023-2030. Cytarabine, one of the segments analyzed in the report, is expected to record a 15.5% CAGR ... Read More
-
Clinical Trial Management Systems (CTMS)
... is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 14.5% over the analysis period 2023-2030. Enterprise-Wide CTMS, one of the segments analyzed in the report, is expected to record a 15.0% ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% ... Read More
-
e-Clinical Trial Technologies
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Clinical Trial Management Systems (CTMS), one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach ... Read More
-
Enzyme Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Enzymes [Pharmaceutical Manufacturing, Diagnostic, Research And Development, And Others]) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the growing pharmaceutical and healthcare sector and the product development activities ... Read More
-
Ophthalmic Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Drug Class (Anti-Allergic, Anti-Inflammatory, Anti-Vegf Agents, And Others), By Dosage Forms (Gels, Capsules/Tablets, Eye Drops, And Others), and by geography is expected to advance at a respectable cagr forecast till 2030 owing to the rising ... Read More
-
Keratoconus - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Keratoconus: Understanding ... Read More
-
Mydriasis - Epidemiology Forecast - 2034
... Out of the total surgeries, cataract surgery accounted for the highest with nearly 920 thousand cases. These cases are expected to change during the study period. Total eye examinations and surgery accounted for nearly 352 ... Read More
-
Prurigo Nodularis: Competitive Landscape
... PN are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast for PN. There is only a single disease-modifying innovator therapy available in the market for PN. The PN pipeline comprises 20 molecules, with ... Read More
-
Soft Tissue Sarcoma: Competitive Landscape
... prevalent cases of STS are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast for STS. Currently, the market space for STS holds many innovator drugs. Prominent companies such as Roche, BMS, Novartis, and ... Read More
-
Zollinger-Ellison Syndrome (Gastrinoma) - Global Clinical Trials Review, 2024
... of Zollinger-Ellison Syndrome (Gastrinoma) Clinical trials scenario. This report provides top line data relating to the clinical trials on Zollinger-Ellison Syndrome (Gastrinoma). Report includes an overview of trial numbers and their average enrollment in top ... Read More
-
Hyperlipidemia - Global Clinical Trials Review, 2024
... report provides top line data relating to the clinical trials on Hyperlipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of ... Read More
Research Assistance
